Clearmind Medicine Inc. Fair Value Of Acquired Receivables
Clearmind Medicine Inc. (CMND) had Fair Value Of Acquired Receivables of $110.10 thousand as of 2023-02-22, per its 6-K filed 2023-06-14.
Discontinued › Notes › Fair Value Measures and Disclosures
ifrs-full:FairValueOfAcquiredReceivables · last filed 2024-03-18
- 2023-01-31: Fair Value Of Acquired Receivables 46.83K CAD.
- 2023-01-16: Fair Value Of Acquired Receivables 51.12K CAD.
- 2022-02-14: Fair Value Of Acquired Receivables 17.58K CAD; Fair Value Of Acquired Receivables as first filed 24.00K CAD.
- 2021-11-26: Fair Value Of Acquired Receivables 21.10K CAD; Fair Value Of Acquired Receivables as first filed 28.80K CAD.
CAD
| Period end | Fair Value Of Acquired Receivables | Fair Value Of Acquired Receivables as first filed |
|---|---|---|
| 2023-01-31 | 46.83K CAD 6-K · filed 2023-03-17 | |
| 2023-01-16 | 51.12K CAD 6-K · filed 2023-03-17 | |
| 2022-02-14 | 17.58K CAD 20-F/A · filed 2024-03-18 | 24.00K CAD 20-F · filed 2023-02-06 |
| 2021-11-26 | 21.10K CAD 20-F/A · filed 2024-03-18 | 28.80K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Fair Value Of Acquired Receivables |
|---|---|
| 2023-02-22 | $110.10K 6-K · filed 2023-06-14 |
| 2023-01-16 | $39.98K 6-K · filed 2023-06-14 |
| 2022-02-14 | $17.58K 6-K · filed 2023-06-14 |
| 2021-11-26 | $21.10K 6-K · filed 2023-06-14 |